Reduced IL-2-induced IL-12 responsiveness in atopic children

Pediatric Allergy and Immunology

Volumn 14, Issue 5, 2003, Pages 351-357

  Zdolsek, Helena Aniansson ^a   Janefjord, Camilla K ^b   Fälth Magnusson, Karin ^b   Jenmalm, Maria C ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Atopic disease; Childhood; IL 12; IL 12 2; IL 2; T cells

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN RECEPTOR; INTERLEUKIN-12 RECEPTOR; MESSENGER RNA;

ARTICLE; ATOPY; BETA CHAIN; BIOSYNTHESIS; BLOOD; CHEMISTRY; CHILD; CHILD WELFARE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; SKIN TEST; SWEDEN; SYMPTOMATOLOGY; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

BIOLOGICAL MARKERS; CHILD; CHILD WELFARE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; SKIN TESTS; STATISTICS; SWEDEN; UP-REGULATION;

EID: 0242416158     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2003.00075.x     Document Type: Article

References (24)

1. ROMAGNANI S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000: 105: 399-408.
2. TRINCHIERI G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994: 84: 4008-27.
3. DESAI BB, QUINN PM, WOLITZKY AG, MONGINI PK, CHIZZONITE R, GATELY MK. IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992: 148: 3125-32.
4. PRESKY DH, YANG H, MINETTI J, et al. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996: 93: 14002-7.
5. ROGGE L, BARBERIS-MAINO L, BIFFI M, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997: 185: 825-31.
6. MATSUI E, KANEKO H, TERAMOTO T, et al. Reduced IFN-γ production in response to IL-12 stimulation and/or reduced IL-12 production in atopic patients. Clin Exp Allergy 2000: 30: 1250-6.
7. 2 chain gene in atopic subjects. Int Arch Allergy Immunol 2001: 124: 117-20.
8. SHIKANO H, KATO Z, KANEKO M, et al. IFN-γ production in response to IL-18 or IL-12 stimulation by peripheral blood mononuclear cells of atopic patients. Clin Exp Allergy 2001: 31: 1263-70.
9. LESTER MR, HOFER MF, GATELY M, TRUMBLE A, LEUNG DYM. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J Immunol 1995: 154: 6174-81.
10. HAYGLASS KT, LI Y, REMPEL JD, WANG MD, SIMONS FER. Exogenous IL-12 and directed induction of human and murine Th1-associated responses. Int Arch Allergy Immunol 1997: 113: 281-3.
11. VAN DER POUW KRAAN TC, BOEIJE LC, DE GROOT ER, et al. Reduced production of IL-12 and IL-12 dependent IFN-γ release in patients with allergic asthma. Clin Exp Allergy 1997: 158: 5560-5.
12. 2 expression in atopic and non-atopic children. Clin Exp Allergy 2001: 31: 1493-500.
13. JENMALM MC, ANIANSSON ZDOLSEK H, HOLT PG, BJÖRKSTÉN B. Expression of and responses to CD2 and CD3 in 18-month-old children with and without atopic dermatitis. Pediatr Allergy Immunol 2000: 11: 175-82.
14. ANIANSSON ZDOLSEK H, ERNERUDH J, HOLT PG, NILSSON J, BJÖRKSTÉ N B. Expression of the T-cell markers CD3, CD4 and CD8 in healthy and atopic children during the first 18 months of life. Int Arch Allergy Immunol 1999: 119: 6-12.
15. KUNZ B, ORANJE AP, LABREZE L, STALDER JF, RING J, TAIEB A. Clinical validation and guidelines for the SCORAD index: concensus report of the, European Task Force on atopic dermatitis. Dermatology 1997: 195: 10-19.
16. HILKENS CMU, MESSER G, TESSELAR K, RIETSCHOTEN AGI, KAPSENBERG ML, WIERENGA EA. Lack of IL-12 signalling in human allergen-specific Th2 cells. J Immune 1996: 157: 4316-21.
17. THIERFELDER WE, VAN DEURSEN JM, YAMAMOTO K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996: 382: 171-4.
18. GAFFEN SL. Signaling domains of the interleukin 2 receptor. Cytokine 2001: 14: 63-77.
19. 2 in allergic rhinitis and chronic sinusitis. Clin Exp Allergy 1999: 29: 1320-5.
20. KING CL, HAKIMI J, SHATA MT, MEDHAT A. IL-12 regulation of parasite antigen-driven IgE production in human helminths infections. J Immunol 1995: 155: 454-61.
21. KOULIS A, ROBINSON DS. The anti-inflammatory effects of interleukin-10 in allergic disease. Clin Exp Allergy 2000: 30: 747-50.
22. ROUSSET F, GARCIA E, DEFRANCE T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992: 89: 1890-3.
23. OHMEN JD, HANIFIN JM, NICKOLOFF BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type reactions. J Immunol 1995: 154: 1956-63.
24. BORISH L, AARONS A, RUMBYRT J, CVIETUSA P, NEGRI J, WENZEL S. Interleukin-10 regulation in normal subjects and in patients with asthma. J Allergy Clin Immunol 1996: 97: 1288-96.